Federal Register of Legislation - Australian Government

Primary content

Instrument 2019 No. R36 Determinations/Veterans' Entitlements as made
This instrument provides assistance for people prescribed mefloquine or tafenoquine, both of which are anti-malarial medications, during their service with the Australian Defence Force. Eligible persons are entitled to one comprehensive health assessment by an authorised general practitioner.
Administered by: Veterans' Affairs
Registered 16 Jul 2019
Tabling HistoryDate
Tabled HR22-Jul-2019
Tabled Senate22-Jul-2019
To be repealed 30 Jun 2023
Repealed by Self Repealing

 

 

 

 

Repatriation Commission

 

 

Veterans’ Entitlements (Anti-Malarial Medications Health Assessment) Determination 2019

 

Instrument 2019 No. R36

 

 

 

The Repatriation Commission, under paragraphs 88A (1)(a) and (d) of the Veterans’ Entitlements Act 1986, makes the following instrument.

 

 

Dated this     11th      of     July     2019

 

 

The Seal of the                                                               )

Repatriation Commission                                              )

was affixed hereto in the                                                ) SEAL

presence of:                                                                    )

                                                                                        )

 

 

……Elizabeth Cosson……

 

……Craig Orme……

ELIZABETH COSSON

 

CRAIG ORME

AM CSC

 

DSC AM CSC

PRESIDENT

 

DEPUTY PRESIDENT

 

 

 

 

 

 

 

 

 

……D Spinks……

 

 

DONALD SPINKS

 

 

AM

 

 

COMMISSIONER

 

 

 

 

1 Name

This instrument is the Veterans’ Entitlements (Anti-Malarial Medications Health Assessment) Determination 2019.

2 Commencement

This instrument commences on the day after it is registered on the Federal Register of Legislation.

3 Authority

This instrument is made under paragraphs 88A(1)(a) and (d) of the Veterans’ Entitlements Act 1986.

4 Purpose

The purpose of this instrument is to enable persons within a class specified in section 6 to receive treatment consisting of one health assessment by an authorised general practitioner.

Note: A person’s health assessment under this instrument is in addition to any other health assessment available to the person as a client of the Department of Veterans’ Affairs.

5 Definitions

In this instrument:

Act means the Veterans’ Entitlements Act 1986.

Australian Defence Force has the same meaning as in the Defence Act 1903.

authorised general practitioner means a general practitioner engaged by an organisation that has entered into a contract with the Commonwealth or the Repatriation Commission, or both, to provide health assessments for the purposes of this instrument.

Note: The term ‘continuous full-time service’ is defined in subsection 5C(1) of the Act.

6 Specified class

For paragraphs 88A(1)(a) and (d) of the Act, the specified class is a person who:

(a)      has taken, or reasonably believes that he or she has taken, mefloquine or tafenoquine as part of his or her service in the Australian Defence Force; and

(b)      has rendered at least one day of continuous full-time service on or after 1 January 1989;

whether or not the person has ceased to be a member of the Australian Defence Force.

Note: Mefloquine and tafenoquine are prescribed anti-malarial medications.

7 Specified kind of treatment

A person who is a member of the specified class in section 6 is eligible to be provided with treatment under Part V of the Act consisting of one health assessment by an authorised general practitioner.

Note: The Treatment Principles under section 90 of the Act, the Repatriation Private Patient Principles under section 90A of the Act and the Repatriation Pharmaceutical Benefits Scheme under section 91 of the Act apply to any treatment provided.

8  Repeal

This instrument is repealed on 30 June 2023.